3D bioprinting for orthopaedic applications: current advances, challenges and regulatory considerations

In the era of personalised medicine, novel therapeutic approaches raise many hopes to address currently unmet medical needs by developing patient-customised treatments. Three-dimensional (3D) bioprinting is rapidly evolving and has the potential to obtain personalised tissue constructs and overcome some limitations of standard tissue engineering approaches. Bioprinting could support a wide range of biomedical applications, such as drug testing, tissue repair or organ transplantation. There is a growing interest for 3D bioprinting in the orthopaedic field, with remarkable scientific and technical advances. However, the full exploitation of 3D bioprinting in medical applications still requires efforts to anticipate the upcoming challenges in translating bioprinted products from bench to bedside. In this review we summarised current trends, advances and challenges in the application of 3D bioprinting for bone and cartilage tissue engineering. Moreover, we provided an analysis of the applicable regulations through the 3D bioprinting process and an overview of available standards covering bioprinting and additive manufacturing.

STANCO Deborah;  URBAN LOPEZ Patricia;  TIRENDI Salvatore;  GIANLUCA Ciardelli;  BARRERO Josefa; 

2021-01-21

Elsevier BV

JRC121046

2405-8866 (print),   

https://www.sciencedirect.com/science/article/pii/S2405886620300300?via%3Dihub,    https://publications.jrc.ec.europa.eu/repository/handle/JRC121046,   

10.1016/j.bprint.2020.e00103 (online),